Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)
Clinical trial NCT06945458 · COMPLETED
Trial details
- NCT number
- NCT06945458
- Sponsor
- Kymera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-17
- Primary completion
- 2025-11-10
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.